(TMHC) Taylor Morn Home - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87724P1066
TMHC: Homes, Communities, Properties, Financial Services
Taylor Morrison Home Corporation (TMHC) stands as a prominent public homebuilder in the U.S., with a rich history dating back to 1936. Headquartered in Scottsdale, Arizona, the company is known for its diverse portfolio, including single-family homes, multi-family units, and master-planned communities. Under brands like Taylor Morrison, Darling Homes Collection, and Esplanade, they operate across key states such as California, Texas, Florida, and others, showcasing their strategic market presence.
Financially, TMHC boasts a market cap of around $6.67 billion, with a P/E ratio of 8.54 and a forward P/E of 7.69, suggesting potential value for investors. The P/B ratio of 1.21 and P/S of 0.85 indicate moderate valuation, reflecting the industrys current landscape. Their financial services, including title insurance and closing solutions, add revenue streams and enhance customer retention through a one-stop approach.
Operational strategies highlight their focus on mixed-use developments under the Urban Form brand, diversifying beyond traditional homebuilding. This approach attracts investors seeking broader real estate exposure. Their emphasis on master-planned communities underscores long-term development commitments, potentially offering stability in a cyclical industry.
Geographic diversity across booming and cooling markets mitigates risk, exposing them to varied economic conditions. Factors like interest rates and land management are crucial, given the industrys cyclical nature. Recent initiatives in sustainability and technology integration could differentiate TMHC, aligning with modern consumer and investor expectations.
Investment considerations include evaluating TMHCs position within the cyclical homebuilding sector, their strategic land holdings, and operational efficiency. While the company offers diversification and potential value, investors should weigh these against industry risks and market conditions.
Additional Sources for TMHC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TMHC Stock Overview
Market Cap in USD | 5,910m |
Sector | Consumer Cyclical |
Industry | Residential Construction |
GiC Sub-Industry | Homebuilding |
IPO / Inception | 2013-04-10 |
TMHC Stock Ratings
Growth 5y | 85.2% |
Fundamental | 31.6% |
Dividend | 0.0% |
Rel. Strength Industry | 11.5 |
Analysts | 4.22/5 |
Fair Price Momentum | 72.68 USD |
Fair Price DCF | 27.19 USD |
TMHC Dividends
No Dividends PaidTMHC Growth Ratios
Growth Correlation 3m | -20.1% |
Growth Correlation 12m | 48.8% |
Growth Correlation 5y | 89.8% |
CAGR 5y | 49.84% |
CAGR/Max DD 5y | 1.22 |
Sharpe Ratio 12m | -0.26 |
Alpha | -9.73 |
Beta | 1.43 |
Volatility | 34.72% |
Current Volume | 1061.6k |
Average Volume 20d | 1243k |
As of March 20, 2025, the stock is trading at USD 60.21 with a total of 1,061,602 shares traded.
Over the past week, the price has changed by +1.23%, over one month by -2.73%, over three months by +1.64% and over the past year by +4.24%.
Neither. Based on ValueRay Fundamental Analyses, Taylor Morn Home is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.64 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TMHC as of March 2025 is 72.68. This means that TMHC is currently undervalued and has a potential upside of +20.71% (Margin of Safety).
Taylor Morn Home has received a consensus analysts rating of 4.22. Therefor, it is recommend to buy TMHC.
- Strong Buy: 3
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TMHC Taylor Morn Home will be worth about 82 in March 2026. The stock is currently trading at 60.21. This means that the stock has a potential upside of +36.16%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 77.3 | 28.4% |
Analysts Target Price | 82.2 | 36.5% |
ValueRay Target Price | 82 | 36.2% |